AAL vs NCI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
AAL
NCI
Investment Advisor Scores
NCI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | AAL | NCI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 46.2963 | 0 | Tie |
| PEG Ratio | 0.8234 | 1.13 | AAL |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 16.3% | -50.8% | AAL |
| Earnings Growth | -88.2% | 34.0% | NCI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.9/100 | 48.4/100 | AAL |
| Profit Margin | -0.6% | 0.2% | NCI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
AAL
NeutralMixed signals - no dominant trend phase, RSI 48
NCI
MarkupPrice above SMA50, rising 50-day trend (61.0% over 20 days), RSI 71
Fundamentals Snapshot
| Metric | AAL | NCI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 6.1 | 0.0 |
| Trailing P/E | — | 150.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | -0.5% |
| Gross Margin | 0.2% | 0.4% |
| Operating Margin | 0.0% | 0.0% |
| EPS | -0.49 | 0.08 |
| Dividend Yield | — | — |